Literature DB >> 20484041

The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.

Dong Zhao1, Han-Qiu Zheng, Zhongmei Zhou, Ceshi Chen.   

Abstract

Fbw7 is a tumor suppressor frequently inactivated in cancers. The KLF5 transcription factor promotes breast cell proliferation and tumorigenesis through upregulating FGF-BP. The KLF5 protein degrades rapidly through the ubiquitin proteasome pathway. Here, we show that the Skp1-CUL1-Fbw7 E3 ubiquitin ligase complex (SCF(Fbw7)) targets KLF5 for ubiquitin-mediated degradation in a GSK3beta-mediated KLF5 phosphorylation-dependent manner. Mutation of the critical S303 residue in the KLF5 Cdc4 phospho-degrons motif ((303)SPPSS) abolishes the protein interaction, ubiquitination, and degradation by Fbw7. Inactivation of endogenous Fbw7 remarkably increases the endogenous KLF5 protein abundances. Endogenous Fbw7 suppresses the FGF-BP gene expression and breast cell proliferation through targeting KLF5 for degradation. These findings suggest that Fbw7 inhibits breast cell proliferation at least partially through targeting KLF5 for proteolysis. This new regulatory mechanism of KLF5 degradation may result in useful diagnostic and therapeutic targets for breast cancer and other cancers. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484041     DOI: 10.1158/0008-5472.CAN-10-0040

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  77 in total

1.  Identification of poly (ADP-ribose) polymerase-1 (PARP-1) as a novel Kruppel-like factor 8-interacting and -regulating protein.

Authors:  Heng Lu; Xianhui Wang; Tianshu Li; Alison M Urvalek; Lin Yu; Jieli Li; Jinghua Zhu; Qishan Lin; Xu Peng; Jihe Zhao
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein.

Authors:  James X Du; Engda G Hagos; Mandayam O Nandan; Agnieszka B Bialkowska; Bing Yu; Vincent W Yang
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

Review 3.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

4.  ML264, A Novel Small-Molecule Compound That Potently Inhibits Growth of Colorectal Cancer.

Authors:  Ainara Ruiz de Sabando; Chao Wang; Yuanjun He; Mónica García-Barros; Julie Kim; Kenneth R Shroyer; Thomas D Bannister; Vincent W Yang; Agnieszka B Bialkowska
Journal:  Mol Cancer Ther       Date:  2015-11-30       Impact factor: 6.261

5.  RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.

Authors:  Zehua Wang; Zhi Nie; Wenlin Chen; Zhongmei Zhou; Qinghua Kong; Arun K Seth; Rong Liu; Ceshi Chen
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

Review 6.  The two faces of FBW7 in cancer drug resistance.

Authors:  Zhiwei Wang; Hidefumi Fukushima; Daming Gao; Hiroyuki Inuzuka; Lixin Wan; Alan W Lau; Pengda Liu; Wenyi Wei
Journal:  Bioessays       Date:  2011-08-30       Impact factor: 4.345

Review 7.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

Review 8.  The role of aberrant proteolysis in lymphomagenesis.

Authors:  Anagh A Sahasrabuddhe; Kojo S J Elenitoba-Johnson
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

9.  The Novel Small-Molecule SR18662 Efficiently Inhibits the Growth of Colorectal Cancer In Vitro and In Vivo.

Authors:  Julie Kim; Chao Wang; Ainara Ruiz de Sabando; Hannah L Cole; Timothy J Huang; Jie Yang; Thomas D Bannister; Vincent W Yang; Agnieszka B Bialkowska
Journal:  Mol Cancer Ther       Date:  2019-07-29       Impact factor: 6.261

Review 10.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.